With the aging population, central nervous system diseases are becoming increasingly widespread. However, the treatment of such diseases represents a challenge mainly due to the presence of the blood-brain barrier, which effectively blocks most of drugs to pass into the central nervous system and impedes the treatment of diseases. Therefore, effective ways of drug transport to the central nervous system are highly required. Polymeric nanoparticles are drug delivery vectors that have high specificity to their targeted sites and increasingly enhance the stability of encapsulated drugs. Poly(amidoamines) are a promising family of synthetic polymers that can be used in nanoparticles synthesis. Nanoparticles synthesized from linear poly(amidoamines) show very good biocompatibility levels and specific targeting properties. Nevertheless, those nanoparticles are mainly synthesized by self-assembly and usually lack long-term stability. In this study we developed innovative poly(amidoamine) nanoparticles synthesized by ultraviolet light assisted photo-crosslinking. The synthesis method had an advantage of being simple, did not require toxic organic solvents and was shown to be easily scaled-up. Moreover, poly(amidoamine) nanoparticles were coated by Polysorbate 80 surfactant, which not only increased the nanoparticles stability but also gave them central nervous system targeting properties. Poly(amidoamine) nanoparticles were able to successfully encapsulate model therapeutic compounds and release them in a slow and controlled manner. Furthermore, the nanoparticles showed high permeability levels across an in vitro blood brain barrier model. The developed poly(amidoamine) nanoparticles show great potential to be used as delivery vectors to the central nervous system.

NOVEL POLY(AMIDOAMINE) NANOPARTICLES DESIGNED FOR DRUG DELIVERY TO THE CENTRAL NERVOUS SYSTEM / S. Gevorgyan ; supervisor: P.MILANI, G. PELICCI, N. TIRELLI. - : . DIPARTIMENTO DI FISICA, 2016 Mar 18. ((27. ciclo, Anno Accademico 2015. [10.13130/gevorgyan-smbat_phd2016-03-18].

NOVEL POLY(AMIDOAMINE) NANOPARTICLES DESIGNED FOR DRUG DELIVERY TO THE CENTRAL NERVOUS SYSTEM

S. Gevorgyan
2016-03-18

Abstract

With the aging population, central nervous system diseases are becoming increasingly widespread. However, the treatment of such diseases represents a challenge mainly due to the presence of the blood-brain barrier, which effectively blocks most of drugs to pass into the central nervous system and impedes the treatment of diseases. Therefore, effective ways of drug transport to the central nervous system are highly required. Polymeric nanoparticles are drug delivery vectors that have high specificity to their targeted sites and increasingly enhance the stability of encapsulated drugs. Poly(amidoamines) are a promising family of synthetic polymers that can be used in nanoparticles synthesis. Nanoparticles synthesized from linear poly(amidoamines) show very good biocompatibility levels and specific targeting properties. Nevertheless, those nanoparticles are mainly synthesized by self-assembly and usually lack long-term stability. In this study we developed innovative poly(amidoamine) nanoparticles synthesized by ultraviolet light assisted photo-crosslinking. The synthesis method had an advantage of being simple, did not require toxic organic solvents and was shown to be easily scaled-up. Moreover, poly(amidoamine) nanoparticles were coated by Polysorbate 80 surfactant, which not only increased the nanoparticles stability but also gave them central nervous system targeting properties. Poly(amidoamine) nanoparticles were able to successfully encapsulate model therapeutic compounds and release them in a slow and controlled manner. Furthermore, the nanoparticles showed high permeability levels across an in vitro blood brain barrier model. The developed poly(amidoamine) nanoparticles show great potential to be used as delivery vectors to the central nervous system.
MILANI, PAOLO
Poly(amidoamine), Nanoparticles, Photocrosslinking
Settore FIS/03 - Fisica della Materia
NOVEL POLY(AMIDOAMINE) NANOPARTICLES DESIGNED FOR DRUG DELIVERY TO THE CENTRAL NERVOUS SYSTEM / S. Gevorgyan ; supervisor: P.MILANI, G. PELICCI, N. TIRELLI. - : . DIPARTIMENTO DI FISICA, 2016 Mar 18. ((27. ciclo, Anno Accademico 2015. [10.13130/gevorgyan-smbat_phd2016-03-18].
Doctoral Thesis
File in questo prodotto:
File Dimensione Formato  
phd_unimi_R09883.pdf

accesso aperto

Descrizione: Tesi Dottorato
Tipologia: Tesi di dottorato completa
Dimensione 2.66 MB
Formato Adobe PDF
2.66 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/366799
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact